NYSE : EVH

Evolent Health, Inc. — Financial statements

Healthcare · Health Information Services · United States

Last price 4.25 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 480.50M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Evolent Health, Inc. (EVH) reported revenue of 2.10B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue2.10B1.88B2.55B1.96B1.35B907.96M
Cost of Revenue1.74B1.48B2.19B1.50B1.04B657.55M
Gross Profit361.64M399.88M367.35M460.47M316.58M250.41M
Selling, General & Admin277.70M288.47M246.64M322.87M269.27M207.78M
Operating Expenses389.47M404.32M343.41M446.29M336.46M267.82M
Operating Income-27.84M-4.43M23.94M14.18M-19.88M-17.41M
Interest Expense-69.21M-57.47M-24.72M-54.20M-15.57M-25.43M
Interest & Investment Income3.55M4.19M5.54M5.26M1.37M407.00K
Earnings From Equity Investments135.00K365.00K-3.44M1.29M4.57M13.18M
Other Non Operating Income (Expenses)379.00K-53.10M68.00K-62.52M-45.89M-146.00K
EBT Excluding Unusual Items-92.98M-110.45M1.39M-96.00M-75.41M-29.40M
Merger & Restructuring Charges-5.58M-5.25M-13.53M-35.24M-11.72M
Impairment of Goodwill-398.00M-398.00M
Gain (Loss) on Sale of Assets14.87M14.87M-8.11M45.94M
Asset Writedown-24.19M-24.07M
Other Unusual Items-20.44M-35.80M-26.71M-38.99M13.33M-34.62M
Pretax Income-502.14M-534.64M-63.04M-202.41M-62.08M-29.80M
Income Tax Expense2.85M-126.00K-1.41M-89.36M-43.38M483.00K
Earnings From Continuing Operations-504.99M-534.51M-61.62M-113.04M-18.70M-30.28M
Earnings From Discontinued Operations-463.00K-7.32M
Net Income to Company-504.99M-534.51M-61.62M-113.04M-19.16M-37.60M
Net Income-504.99M-534.51M-61.62M-113.04M-19.16M-37.60M
Preferred Dividends & Other Adjustments6.07M44.89M31.83M29.22M
Net Income to Common-511.06M-579.40M-93.45M-142.26M-19.16M-37.60M
Shares Outstanding (Basic)112.52M114.21M114.68M111.25M93.70M86.07M
Shares Outstanding (Diluted)112.52M114.21M114.68M111.25M93.70M86.07M
EPS (Basic)-4.54-5.07-0.81-1.28-0.20-0.44
EPS (Diluted)-4.54-5.07-0.81-1.28-0.20-0.44
Free Cash Flow22.94M-52.69M-14.35M113.84M-59.08M11.25M
Free Cash Flow Per Share0.20-0.46-0.121.02-0.630.13
Gross Margin17.24%21.31%14.38%23.45%23.42%27.58%
Operating Margin-1.33%-0.24%0.94%0.72%-1.47%-1.92%
Profit Margin-24.37%-30.88%-3.66%-7.24%-1.42%-4.14%
Free Cash Flow Margin1.09%-2.81%-0.56%5.80%-4.37%1.24%
EBITDA61.04M88.22M95.11M110.90M20.32M16.12M
EBITDA Margin2.91%4.70%3.72%5.65%1.50%1.78%
D&A For EBITDA88.87M92.65M71.17M96.72M40.20M33.54M
EBIT-27.84M-4.43M23.94M14.18M-19.88M-17.41M
EBIT Margin-1.33%-0.24%0.94%0.72%-1.47%-1.92%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents115.70M151.86M104.20M192.82M188.20M266.28M
Cash & Short-Term Investments115.70M151.86M104.20M192.82M188.20M266.28M
Accounts Receivable449.12M309.86M414.68M446.75M254.68M130.60M
Receivables449.12M309.86M414.68M446.75M254.68M130.60M
Prepaid Expenses22.70M18.52M28.94M30.33M20.68M51.39M
Restricted Cash22.99M26.13M59.30M13.77M14.49M75.69M
Total Current Assets610.51M506.37M607.12M683.67M478.05M523.96M
Property, Plant & Equipment4.93M7.36M10.59M19.28M63.20M60.37M
Long-Term Investments8.76M8.97M8.59M4.89M4.47M5.46M
Goodwill694.43M694.48M1.14B1.12B722.77M426.30M
Other Intangible Assets634.13M662.74M748.86M822.91M516.48M350.98M
Long-Term Accounts Receivable4.88M
Long-Term Deferred Tax Assets2.00M1.50M1.00M
Long-Term Deferred Charges14.05M13.54M13.38M12.12M17.46M32.62M
Other Long-Term Assets5.08M3.78M17.07M19.89M14.84M14.89M
Total Assets1.97B1.90B2.54B2.68B1.82B1.42B
Accounts Payable38.82M59.78M96.03M48.25M57.17M96.08M
Accrued Expenses72.86M116.74M100.08M206.23M163.66M159.10M
Current Portion of Long-Term Debt171.47M
Current Portion of Leases1.54M15.34M26.72M9.74M7.12M7.07M
Current Unearned Revenue1.21M1.20M2.51M5.98M5.76M11.94M
Other Current Liabilities378.40M192.20M318.70M404.05M199.73M171.29M
Total Current Liabilities492.83M385.26M715.50M674.24M433.44M445.49M
Long-Term Debt966.47M970.54M490.52M597.05M412.99M215.68M
Long-Term Leases2.43M3.82M24.97M38.01M56.01M57.72M
Long-Term Unearned Revenue110.00K1.17M2.53M4.44M
Long-Term Deferred Tax Liabilities9.94M7.51M10.90M13.31M4.74M1.40M
Other Long-Term Liabilities117.00M116.81M111.09M110.40M48.16M1.09M
Total Liabilities1.59B1.48B1.35B1.43B957.88M725.83M
Common Stock1.19M1.18M1.17M1.15M1.01M908.00K
Additional Paid-In Capital1.82B1.79B1.80B1.81B1.49B1.34B
Retained Earnings-1.37B-1.32B-780.82M-719.19M-606.15M-626.78M
Treasury Stock-61.43M-61.43M-21.12M-21.12M-21.12M-21.12M
Comprehensive Income & Other-3.63M-2.62M-1.75M-1.26M-1.18M-362.00K
Total Common Equity383.22M415.19M1.00B1.07B859.42M693.63M
Shareholders' Equity383.22M415.19M1.19B1.25B859.42M693.63M
Total Liabilities & Equity1.97B1.90B2.54B2.68B1.82B1.42B
Total Debt970.43M989.70M713.67M644.80M476.12M280.47M
Net Cash (Debt)-854.73M-837.84M-609.47M-451.97M-287.92M-14.19M
Net Cash Per Share-7.60-7.34-5.31-4.06-3.07-0.16
Filing Date Shares Outstanding113.06M111.64M115.05M113.89M109.51M89.29M
Total Common Shares Outstanding112.68M111.63M115.04M113.89M99.96M89.22M
Working Capital117.68M121.11M-108.38M9.43M44.61M78.47M
Book Value Per Share3.403.728.709.388.607.77
Tangible Book Value-945.34M-942.02M-884.92M-871.75M-379.84M-83.65M
Tangible Book Value Per Share-8.39-8.44-7.69-7.65-3.80-0.94
Machinery15.87M16.99M15.72M22.80M34.31M25.55M
Leasehold Improvements787.00K1.44M1.48M1.05M14.93M15.32M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-504.99M-534.51M-61.62M-113.04M-19.16M-37.60M
Depreciation & Amortization88.87M92.65M71.17M96.72M40.20M33.54M
Other Amortization40.52M37.80M33.95M41.46M52.36M57.59M
Loss (Gain) From Sale of Assets-14.87M-14.87M8.11M-45.94M
Asset Writedown & Restructuring Costs398.00M398.00M24.19M24.07M
Loss (Gain) on Equity Investments-135.00K-365.00K3.44M-1.29M-4.57M-13.18M
Stock-Based Compensation42.93M39.74M39.75M40.50M33.98M16.71M
Other Operating Activities15.82M77.78M24.45M24.18M-7.88M34.49M
Change in Accounts Receivable-121.48M73.70M32.06M-164.69M-102.98M-5.78M
Change in Accounts Payable-29.36M6.64M4.25M-6.72M13.16M7.25M
Change in Unearned Revenue-1.12M-1.30M-3.47M-263.00K-6.51M-739.00K
Change in Other Net Operating Assets140.13M-136.42M-149.40M193.57M-10.62M-14.38M
Operating Cash Flow54.32M38.84M18.77M142.58M-11.55M38.75M
Capital Expenditures-31.37M-91.53M-33.12M-28.75M-47.52M-27.50M
Sale of Property, Plant & Equipment91.31M91.31M577.00K3.49M
Cash Acquisitions-19.50M-388.25M-248.11M-46.50M
Investment in Securities348.00K-14.00K-10.31M870.00K5.55M11.72M
Other Investing Activities30.97M43.00M
Investing Cash Flow60.29M-233.00K-62.93M-415.54M-259.12M-15.79M
Long-Term Debt Issued408.05M58.58M647.49M219.74M
Long-Term Debt Repaid-342.98M-464.20M-98.85M
Net Debt Issued (Repaid)-103.44M65.06M58.58M183.29M219.74M-98.85M
Issuance of Common Stock3.46M12.52M4.45M13.29M
Repurchase of Common Stock-42.42M-45.22M-15.70M-15.29M-18.32M-3.85M
Preferred Dividends Paid-1.93M-11.13M-20.09M-18.79M
Dividends Paid-1.93M-11.13M-20.09M-18.79M
Other Financing Activities-2.03M-44.64M-26.82M-48.39M-74.33M59.86M
Financing Cash Flow-149.82M-35.92M-565.00K281.34M131.54M-29.55M
Foreign Exchange Rate Adjustments-1.29M-486.00K-229.00K-79.00K-657.00K-52.00K
Net Cash Flow-36.50M2.20M-44.96M8.30M-139.78M-6.64M
Free Cash Flow22.94M-52.69M-14.35M113.84M-59.08M11.25M
Free Cash Flow Margin1.09%-2.81%-0.56%5.80%-4.37%1.24%
Free Cash Flow Per Share0.20-0.46-0.121.02-0.630.13
Levered Free Cash Flow126.85M40.96M-48.00M162.10M12.57M93.58M
Unlevered Free Cash Flow158.78M69.08M-36.09M192.17M20.00M91.42M
Cash Interest Paid41.16M41.16M20.21M53.59M6.27M7.11M
Cash Income Tax Paid2.60M2.60M1.40M4.90M1.40M551.00K
Change in Working Capital-11.83M-57.38M-116.56M21.89M-106.94M-13.64M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization503.68M446.40M1.29B3.80B2.80B2.43B
Enterprise Value1.36B1.41B2.02B4.44B3.12B2.48B
Last Close Price4.304.0011.2533.0328.0827.67
Forward PE12.8116.8813.6638.4044.3257.19
PS Ratio0.240.240.511.932.072.68
PB Ratio1.261.071.093.053.263.50
P/FCF Ratio21.8333.36216.09
P/OCF Ratio9.2211.4968.9626.6362.75
PEG Ratio1.911.911.911.911.91
EV/Sales Ratio0.650.750.792.262.312.73
EV/EBITDA Ratio22.2116.0121.2440.05153.52153.84
EV/EBIT Ratio84.36313.22
EV/FCF Ratio59.0939.02220.47
Debt / Equity Ratio2.532.380.600.520.550.40
Debt / EBITDA Ratio14.9910.696.905.1613.628.21
Debt / FCF Ratio42.305.6624.93
Net Debt / Equity Ratio2.232.020.510.360.340.02
Net Debt / EBITDA Ratio14.009.506.414.0814.170.88
Net Debt / FCF Ratio37.26-15.90-42.463.97-4.871.26
Asset Turnover0.950.840.980.870.830.65
Quick Ratio1.151.200.720.951.020.89
Current Ratio1.241.310.851.011.101.18
Return on Equity (ROE)-66.97%-66.54%-5.06%-10.74%-2.41%-4.61%
Return on Assets (ROA)-0.78%-0.12%0.57%0.39%-0.77%-0.78%
Return on Invested Capital (ROIC)-2.25%-0.29%1.37%1.00%-2.14%-2.54%
Return on Capital Employed (ROCE)-1.90%-0.30%1.30%0.70%-1.40%-1.80%
Earnings Yield-101.95%-119.74%-4.76%-2.98%-0.69%-1.55%
FCF Yield4.58%-11.80%-1.11%3.00%-2.11%0.46%
Buyback Yield / Dilution2.39%0.41%-3.08%-18.73%-8.87%-1.34%